Details for New Drug Application (NDA): 077841
✉ Email this page to a colleague
NDA 077841 describes PENTOSTATIN, which is a drug marketed by Rising and West-ward Pharms Int and is included in two NDAs. Additional details are available on the PENTOSTATIN profile page.
The generic ingredient in PENTOSTATIN is pentostatin. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the pentostatin profile page.
The generic ingredient in PENTOSTATIN is pentostatin. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the pentostatin profile page.
Summary for 077841
| Tradename: | PENTOSTATIN |
| Applicant: | West-ward Pharms Int |
| Ingredient: | pentostatin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 077841
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 10MG/VIAL | ||||
| Approval Date: | Aug 7, 2007 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
